# Distinct memory CD4+ T cell subset tropism of two CCR5-tropic HIV-1 in a rapid progressor

**Authors:** Manukumar Honnayakanahalli Marichannegowda, Yasmine Farah, Meera Bose, Eric Sanders-Buell, David King, Leilani Francisco, Leigh Anne Eller, Abdur Rashid, Sodsai Tovanabutra, Nelson L. Michael, Merlin L. Robb, Hongshuo Song

PMC · DOI: 10.1128/asmcr.00101-25 · ASM Case Reports · 2025-08-26

## TL;DR

This study shows that two CCR5-tropic HIV-1 viruses prefer different memory CD4+ T cell subsets in a rapid progressor, which could impact HIV treatment and cure strategies.

## Contribution

The study reveals distinct memory CD4+ T cell subset tropism of two CCR5-tropic HIV-1 viruses in a single patient.

## Key findings

- The transmitted/founder virus was compartmentalized in central memory CD4+ T cells.
- The superinfecting virus was compartmentalized in effector memory CD4+ T cells.
- The transmitted/founder virus showed over 100-fold higher resistance to Maraviroc than the superinfecting virus.

## Abstract

Low HIV-1 infection level in the central memory CD4+ T cell subset is a hallmark of both non-progressive HIV infection and non-pathogenetic SIV infection in the natural hosts. However, an important gap in knowledge is whether CCR5-tropic HIV-1 variants have different memory CD4+ T cell subset preferences.

Here, we identified clear compartmentalization of two CCR5-tropic HIV-1 in different memory CD4+ T cell subsets in a rapid progressor. Participant 40512 was identified in the RV217 cohort. While the transmitted/founder (T/F) virus in 40512 was compartmentalized in the central memory CD4+ T cells, the superinfecting virus was compartmentalized in the effector memory CD4+ T cells. Both viruses rely on CCR5 to infect primary CD4+ T cells. The T/F virus is more than 100-fold more resistant to the CCR5 inhibitor Maraviroc than the superinfecting virus.

This case report demonstrates that CCR5 HIV-1 variants have distinct memory CD4+ T cell subset preferences in vivo. Because CD4+ T cell subset targeting is highly relevant for HIV-1 pathogenesis, understanding the underlying molecular mechanisms may provide deeper insights into HIV-1 therapeutics and functional cure.

## Linked entities

- **Chemicals:** Maraviroc (PubChem CID 3002977)
- **Diseases:** SIV (MONDO:0700112)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}
- **Diseases:** HIV infection (MESH:D015658), SIV infection (OMIM:270100)
- **Chemicals:** Maraviroc (MESH:D000077592)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12584166/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12584166/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12584166/full.md

---
Source: https://tomesphere.com/paper/PMC12584166